FDA 483 - Liebel-Flarsheim Company LLC - April 08, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Liebel-Flarsheim Company LLC, a drug product manufacturer in Raleigh, NC, was cited for significant deficiencies during an FDA inspection. Observations included inadequate investigations into out-of-specification results, poor maintenance of aseptic processing areas and facility infrastructure, and the use of non-validated spreadsheets for critical laboratory testing. Additionally, employee training and adherence to aseptic sampling procedures were found to be insufficient.
ID · 91593c21-3eff-43ab-af49-b2eaf6374da9